10 Years of belimumab experience: What have we learnt?

Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease affecting both adults and children. Belimumab is the only biologic approved for SLE, and the first in a class of drugs known as B-lymphocyte stimulator-specific inhibitors. The introduction of intravenous belimumab in 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Levy, Roger A, Gonzalez-Rivera, Tania, Khamashta, Munther, Fox, Norma Lynn, Jones-Leone, Angela, Rubin, Bernie, Burriss, Susan W, Gairy, Kerry, van Maurik, Andre, Roth, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564244/
https://www.ncbi.nlm.nih.gov/pubmed/34238087
http://dx.doi.org/10.1177/09612033211028653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564244/
https://www.ncbi.nlm.nih.gov/pubmed/34238087
http://dx.doi.org/10.1177/09612033211028653

Ejemplares similares